Table 2.
Number | Percentage | ||
---|---|---|---|
Age (Years) | Median: 49 | ||
Range: 18 to 90 | |||
Gender | Female | 250 | 47.7 |
Male | 274 | 52.3 | |
Disease stage | I-II | 224 | 42.7 |
III- IV | 300 | 57.3 | |
Smoking | Active smoker | 139 | 26.5 |
Prior-smoker | 65 | 12.4 | |
Never smoked | 314 | 60.0 | |
Unknown | 6 | 1.1 | |
BMI (kg/m2) | ≤ 30 | 358 | 68.3 |
> 30 | 161 | 30.7 | |
LDH | Low | 226 | 43.1 |
High | 291 | 55.5 | |
ECOG Performance Status (PS) | 0 to 1 | 439 | 83.8 |
2 | 43 | 8.2 | |
3 to 4 | 42 | 8.0 | |
Hemoglobin (g/L) | < 100 | 57 | 10.9 |
≥ 100 | 466 | 88.9 | |
Response to Treatment | Complete Response (CR) | 402 | 76.7 |
Partial Response (PR) | 38 | 7.3 | |
Disease Progression (DP) | 63 | 12.0 | |
NA | 12 | 2.3 | |
History of VTE | 45 | 8.6 | |
Neutropenia (ANC< 1000) | 14 | 2.7 | |
Extranodal localization | 350 | 66.8 | |
Mediastinal involvement | 207 | 39.5 | |
Bulky Disease | 178 | 34.0 | |
Salvage chemotherapy | 86 | 16.4 |
BMI: Body Mass Index; LDH: Lactic Dehydrogenase; ECOG: Eastern Cooperative Oncology Group; NA: Not available; VTE: Venous Thromboembolism; ANC: Absolute Neutrophil Count.